How does biotechnology reconcile ties to big bad pharmaceuticals industry?

Don Seiffert | Boston Business Journal&nbsp|&nbsp
The GLP aggregated and excerpted this blog/article to reflect the diversity of news, opinion and analysis. As the CEO of ...

Regulatory delays and ‘Jurassic Park’ may have ruined prospects for AquaBounty GE salmon

Don Seiffert | Boston Business Journal&nbsp|&nbsp
The Maynard-based biotech company AquaBounty has been working to get a genetically altered salmon that grows faster than conventional, Atlantic ...

Harvard Bioscience stem cells in Russian tracheal transplants

Julie Donnelly | Boston Business Journal&nbsp|&nbsp
(Nasdaq:HBIO), a life sciences tools company, says the first two successful stem cells laryngotracheal transplants have been completed in Russia, ...
glp menu logo outlined

Newsletter Subscription

* indicates required
Email Lists